產(chǎn)品名稱 | 磷酸化cyclinD1抗體 |
英文名稱 | Anti-Phospho-CyclinD1(Thr286) |
規(guī)格 | 0.1ml/100μg |
濃度 | 1mg/1ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱 Anti-Phospho-Cyclin D1 (Thr286)
中文名稱 磷酸化cyclin D1抗體
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來(lái)源 Rabbit
交叉反應(yīng) Human, Dog, Cow, Sheep
產(chǎn)品類型 一抗 磷酸化抗體
研究領(lǐng)域 腫瘤 細(xì)胞生物 表觀遺傳學(xué)
蛋白分子量 predicted molecular weight: 34kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derivedfrom human Cyclin D1 around the phosphorylation site of Thr286
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
保存條件 Store at -20 °C for one year.
別 名 Cyclin D1 (phospho T286); p-Cyclin D1 (phospho T286);AI327039; B cell ccl/lymphoma 1; B cell leukemia 1; B-cell CLL/lymphoma 1;B-cell leukemia 1; B-cell lymphoma 1 protein; BCL-1; BCL1; BCL1 oncogene; CCND1; CCND1; CCND1 protein; CCND1/FSTL3 fusion gene, included; CCND1/IGHG1 fusiongene; CCND1/IGHG1 fusion gene, included; CCND1/IGLC1 fusion gene, included;CCND1/PTH fusion gene, included; cD1; Cyclin D1; Cyl-1; D11S287E; G1/S specificcyclin D1; MGC137744; Parathyroid adenomatosis 1; PRAD1; PRAD1 oncogene;U21B31; CCND1_HUMAN.
